Fourth Amendment to Master Service Agreement, dated September 1, 2021, by and between the Registrant and inVentiv Commercial Services, LLC
Information in this exhibit identified by [***] is confidential and has been excluded pursuant to Item 601(b)(10)(iv) of Regulation S-K because it is both (i) not material and (ii) the type of information that the registrant customarily and actually treats as private and confidential.
Exhibit 10.24
FOURTH AMENDMENT TO
PROJECT AGREEMENT
(DETAILING – FIELD TEAM)
This Fourth Amendment (the “Amendment”) entered into as of the last date of signature herein and made effective as of September 1, 2021 (the “Amendment Effective Date”) is made by and between Syneos Health Commercial Services, LLC, f/k/a inVentiv Commercial Services LLC, with an office at 500 Atrium Drive, Somerset, N.J. 08873 (“Syneos Health”) and Agile Therapeutics, Inc. with an office located at 500 College Road East, Suite 310, Princeton, New Jersey 08540 (the “Client”). Syneos Health and Client may each be referred to herein as a “Party” and, collectively, as the “Parties.”
W I T N E S S E T H:
WHEREAS, Syneos Health and Client are parties to a Project Agreement (Detailing – Field Team) made as of April 30, 2020, First Amendment to Project Agreement (Detailing – Field Team) dated June 1, 2020, Second Amendment to Project Agreement (Detailing – Field Team) dated January 1, 2021 and Third Amendment to Project Agreement (Detailing – Field Team) dated July 1, 2021 (collectively, the “Agreement”); and
WHEREAS, Syneos Health and Client desire to amend the Agreement as set forth herein.
NOW THEREFORE, in consideration of the premises and other good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, it is agreed as follows:
Position | Headcount |
[***] | |
[***] | [***] |
[***] | [***] |
[***] | [***] |
[***] | [***] |
[***] | [***] |
The Amended and Restated Exhibit F, “Compensation – Fixed Fees, Variable Fees and Pass-through Costs,” is amended as follows:
(a) | The table in Section I, “Fixed Fees,” is hereby deleted in its entirety and replaced with the below table. |
Position | Headcount |
[***] | |
[***] | [***] |
[***] | [***] |
[***] | [***] |
[***] | [***] |
[***] | [***] |
(b) | Section I(b), “Fixed Monthly Fee,” paragraph (i) is hereby amended and restated as follows: |
(i) | Commencing on the [***] Date, Client shall pay Syneos Health [***] as follows: |
[***] | [***] |
[***] | [***] |
[***]
Amendment constitute the complete and exclusive statement of its terms and shall supersede any prior agreement with respect to the subject matter hereof.
WHEREFORE, the parties hereto have caused this Amendment to be executed by their duly authorized representatives.
AGILE THERAPEUTICS, INC. | SYNEOS HEALTH COMMERCIAL SERVICES, LLC |
By: _/s/ Al Altomari__________________By: _/s/ Todd Tomasoski
Name: Name: Todd Tomasoski
Title:Title: Vice President, Global Deal Management
Date: Date: Dec 28, 2021